Market Overview

Jefferies Raises PT On Auxilium Pharmaceuticals To $39


Jefferies & Company has raised the price target on Auxilium Pharmaceuticals (NASDAQ: AUXL) from $36 to $39 and maintains its Buy rating.

Posted-In: Auxilium Pharmaceuticals Jefferies & CompanyPrice Target Analyst Ratings


Related Articles (AUXL)

View Comments and Join the Discussion!

Latest Ratings

TOLGoldman SachsInitiates Coverage On42.0
KBHGoldman SachsInitiates Coverage On36.0
YEXTSunTrust Robinson HumphreyMaintains28.0
LHCGSunTrust Robinson HumphreyMaintains160.0
DLRSunTrust Robinson HumphreyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

McAfee to Acquire Sentrigo to Enhance Database Security Portfolio

Wedbush Says HALO Is "No Fallen Angel"